Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001741533-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-04 | 2026-03-02 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $10.36 | +40.0K | 101.3K | +65% | +$414.4K |
| DM | 2026-03-04 | 2026-03-02 | KNSA | Paolini John F. | Chief MEDICAL Off | S - Sale+OE | $44.82 | -40.0K | 89.3K | -31% | -$1.79M |
| D | 2026-03-04 | 2026-03-02 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $0.00 | -40.0K | 58.4K | -41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2026-03-02 | M | A | 40,000 | $10.36 | 101,324 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2026-03-02 | S | D | 5,714 | $45.92 | 61,324 | D | — | — | (F4) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.56 and $46.09. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Common | Class A Ordinary Share | 2026-03-02 | S | D | 22,223 | $44.88 | 67,038 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $44.555 and $45.49. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 4 | Common | Class A Ordinary Share | 2026-03-02 | S | D | 12,063 | $44.20 | 89,261 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $43.555 and $44.55. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 5 | Derivative | Share Option | 2026-03-02 | M | D | 40,000 | $0.00 | 58,424 | D | $10.36 · — to 2028-02-29 | 40,000 Class A Ordinary Share | (F5) The option is fully vested and exercisable. |